Suppr超能文献

miR-216b-5p对肝癌细胞系中UGT2B表达和活性的调控

Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines.

作者信息

Dluzen Douglas F, Sutliff Aimee K, Chen Gang, Watson Christy J W, Ishmael Faoud T, Lazarus Philip

机构信息

National Institute on Aging, National Institutes of Health, Baltimore, Maryland (D.F.D.); Department of Pulmonary Medicine, Penn State University College of Medicine, Hershey, Pennsylvania (F.T.I.); and Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, Washington (A.K.S., G.C., C.W., P.L.).

National Institute on Aging, National Institutes of Health, Baltimore, Maryland (D.F.D.); Department of Pulmonary Medicine, Penn State University College of Medicine, Hershey, Pennsylvania (F.T.I.); and Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, Washington (A.K.S., G.C., C.W., P.L.)

出版信息

J Pharmacol Exp Ther. 2016 Oct;359(1):182-93. doi: 10.1124/jpet.116.235044. Epub 2016 Jul 29.

Abstract

The UDP-glucuronosyltransferase (UGT) 2B enzymes are important in the detoxification of a variety of endogenous and exogenous compounds, including many hormones, drugs, and carcinogens. Identifying novel mechanisms governing their expression is important in understanding patient-specific response to drugs and cancer risk factors. In silico prediction algorithm programs were used to screen for microRNAs (miRNAs) as potential regulators of UGT2B enzymes, with miR-216b-5p identified as a potential candidate. Luciferase data suggested the presence of a functional miR-216b-5p binding motif within the 3' untranslated regions of UGTs 2B7, 2B4, and 2B10. Overexpression of miR-216b-5p mimics significantly repressed UGT2B7 (P < 0.001) and UGT2B10 (P = 0.0018) mRNA levels in HuH-7 cells and UGT2B4 (P < 0.001) and UGT2B10 (P = 0.018) mRNA in Hep3B cells. UGT2B7 protein levels were repressed in both HuH-7 and Hep3B cells in the presence of increasing miR-216b-5p concentrations, corresponding with significant (P < 0.001 and P = 0.011, respectively) decreases in glucuronidation activity against the UGT2B7-specific substrate epirubicin. Inhibition of endogenous miR-216b-5p levels significantly increased UGT2B7 mRNA levels in HuH-7 (P = 0.021) and Hep3B (P = 0.0068) cells, and increased epirubicin glucuronidation by 85% (P = 0.057) and 50% (P = 0.012) for HuH-7 and Hep3B cells, respectively. UGT2B4 activity against codeine and UGT2B10 activity against nicotine were significantly decreased in both HuH-7 and Hep3B cells (P < 0.001 and P = 0.0048, and P = 0.017 and P = 0.043, respectively) after overexpression of miR-216b-5p mimic. This is the first evidence that miRNAs regulate UGT 2B7, 2B4, and 2B10 expression, and that miR-216b-5p regulation of UGT2B proteins may be important in regulating the metabolism of UGT2B substrates.

摘要

UDP-葡萄糖醛酸基转移酶(UGT)2B家族酶在多种内源性和外源性化合物的解毒过程中发挥着重要作用,这些化合物包括许多激素、药物和致癌物。识别调控其表达的新机制,对于理解患者对药物的特异性反应以及癌症风险因素具有重要意义。利用计算机预测算法程序筛选作为UGT2B酶潜在调节因子的微小RNA(miRNA),其中miR-216b-5p被确定为一个潜在候选分子。荧光素酶数据表明,在UGT 2B7、2B4和2B10的3'非翻译区内存在一个功能性的miR-216b-5p结合基序。miR-216b-5p模拟物的过表达显著抑制了HuH-7细胞中UGT2B7(P < 0.001)和UGT2B10(P = 0.0018)的mRNA水平,以及Hep3B细胞中UGT2B4(P < 0.001)和UGT2B10(P = 0.018)的mRNA水平。在HuH-7和Hep3B细胞中,随着miR-216b-5p浓度的增加,UGT2B7蛋白水平均受到抑制,这与针对UGT2B7特异性底物表柔比星的葡萄糖醛酸化活性显著降低(分别为P < 0.001和P = 0.011)相对应。抑制内源性miR-216b-5p水平可显著提高HuH-7(P = 0.021)和Hep3B(P = 0.0068)细胞中UGT2B7的mRNA水平,并且HuH-7和Hep3B细胞中表柔比星葡萄糖醛酸化分别增加85%(P = 0.057)和50%(P = 0.012)。在过表达miR-216b-5p模拟物后,HuH-7和Hep3B细胞中UGT2B4针对可待因的活性以及UGT2B10针对尼古丁的活性均显著降低(分别为P < 0.001和P = 0.0048,以及P = 0.017和P = 0.043)。这是miRNA调节UGT 2B7、2B4和2B10表达的首个证据,并且miR-216b-5p对UGT2B蛋白的调节可能在调控UGT2B底物的代谢中具有重要作用。

相似文献

1
Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines.
J Pharmacol Exp Ther. 2016 Oct;359(1):182-93. doi: 10.1124/jpet.116.235044. Epub 2016 Jul 29.
2
Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver.
Mol Pharmacol. 2019 Dec;96(6):674-682. doi: 10.1124/mol.119.115881. Epub 2019 Sep 25.
4
Regulation of UDP-Glucuronosyltransferases UGT2B4 and UGT2B7 by MicroRNAs in Liver Cancer Cells.
J Pharmacol Exp Ther. 2017 Jun;361(3):386-397. doi: 10.1124/jpet.116.239707. Epub 2017 Apr 7.
6
Regulation of UDP-Glucuronosyltransferase 2B15 by miR-331-5p in Prostate Cancer Cells Involves Canonical and Noncanonical Target Sites.
J Pharmacol Exp Ther. 2018 Apr;365(1):48-59. doi: 10.1124/jpet.117.245936. Epub 2018 Jan 24.
7
Regulation of UGT2A1 by miR-196a-5p and miR-196b-5p.
J Pharmacol Exp Ther. 2019 May;369(2):234-243. doi: 10.1124/jpet.118.255935. Epub 2019 Mar 8.
8
Regulation of human UDP-glycosyltransferase () genes by miRNAs.
Drug Metab Rev. 2022 May;54(2):120-140. doi: 10.1080/03602532.2022.2048846. Epub 2022 Mar 11.
9
UGT2B gene expression analysis in multiple tobacco carcinogen-targeted tissues.
Drug Metab Dispos. 2014 Apr;42(4):529-36. doi: 10.1124/dmd.113.054718. Epub 2014 Jan 23.
10
LncRNA KCNQ1OT1 acts as miR-216b-5p sponge to promote colorectal cancer progression via up-regulating ZNF146.
J Mol Histol. 2021 Jun;52(3):479-490. doi: 10.1007/s10735-020-09942-0. Epub 2021 Jan 4.

引用本文的文献

1
Biochemical and genetic biomarkers associated with nicotine dependence in Mexican smokers.
Pharmacol Res Perspect. 2023 Oct;11(5):e01142. doi: 10.1002/prp2.1142.
2
Novel Approaches to Characterize Individual Drug Metabolism and Advance Precision Medicine.
Drug Metab Dispos. 2023 Oct;51(10):1238-1253. doi: 10.1124/dmd.122.001066. Epub 2023 Jul 7.
3
The Uridine diphosphate (UDP)-glycosyltransferases (UGTs) superfamily: the role in tumor cell metabolism.
Front Oncol. 2023 Jan 19;12:1088458. doi: 10.3389/fonc.2022.1088458. eCollection 2022.
5
The miR-216/miR-217 Cluster Regulates Lipid Metabolism in Laying Hens With Fatty Liver Syndrome PPAR/SREBP Signaling Pathway.
Front Vet Sci. 2022 May 31;9:913841. doi: 10.3389/fvets.2022.913841. eCollection 2022.
6
MicroRNAs and cancer drug resistance: over two thousand characters in search of a role.
Cancer Drug Resist. 2019 Sep 19;2(3):618-633. doi: 10.20517/cdr.2019.55. eCollection 2019.
7
LINC01578 affects the radiation resistance of lung cancer cells through regulating microRNA-216b-5p/TBL1XR1 axis.
Bioengineered. 2022 Apr;13(4):10721-10733. doi: 10.1080/21655979.2022.2051881.
8
The Roles of microRNAs in Cancer Multidrug Resistance.
Cancers (Basel). 2022 Feb 21;14(4):1090. doi: 10.3390/cancers14041090.
10
Expression of UDP Glucuronosyltransferases and is associated with methylation status in prostate cancer cells.
Epigenetics. 2021 Mar;16(3):289-299. doi: 10.1080/15592294.2020.1795601. Epub 2020 Jul 27.

本文引用的文献

2
Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer.
J Steroid Biochem Mol Biol. 2016 Jan;155(Pt A):85-93. doi: 10.1016/j.jsbmb.2015.09.021. Epub 2015 Sep 15.
3
Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines.
J Pharmacol Exp Ther. 2015 Sep;354(3):417-25. doi: 10.1124/jpet.115.226118. Epub 2015 Jul 10.
5
UGT2B gene expression analysis in multiple tobacco carcinogen-targeted tissues.
Drug Metab Dispos. 2014 Apr;42(4):529-36. doi: 10.1124/dmd.113.054718. Epub 2014 Jan 23.
6
Regulation of UDP-glucuronosyltransferase 1A1 expression and activity by microRNA 491-3p.
J Pharmacol Exp Ther. 2014 Mar;348(3):465-77. doi: 10.1124/jpet.113.210658. Epub 2014 Jan 7.
7
Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review.
Pharmacol Ther. 2014 Jan;141(1):92-116. doi: 10.1016/j.pharmthera.2013.09.002. Epub 2013 Sep 27.
8
MiR-216a and miR-216b as markers for acute phased pancreatic injury.
Biomed Res. 2013 Aug;34(4):179-88. doi: 10.2220/biomedres.34.179.
9
Characterization of raloxifene glucuronidation: potential role of UGT1A8 genotype on raloxifene metabolism in vivo.
Cancer Prev Res (Phila). 2013 Jul;6(7):719-30. doi: 10.1158/1940-6207.CAPR-12-0448. Epub 2013 May 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验